Evidence map›Paper›PMID 27849179›Full record

ArticleInfection and immunity2017

β-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity.

Sahar Hasim, David P Allison, Scott T Retterer, Alex Hopke, Robert T Wheeler, Mitchel J Doktycz, Todd B Reynolds

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. A COmBio · 2024
    Article
  8. Article
  9. Development of Echinocandin Resistance inJournal of fungi (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Bending stiffness ofLab on a chip · 2022
    Article
  14. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Back to Nature: CombatingAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sahar HasimDepartment of Microbiology, University of Tennessee, Knoxville, Tennessee, USA.
David P AllisonBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Scott T RettererBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Alex HopkeDepartment of Molecular and Biomedical Sciences, University of Maine, Orono, Maine, USA.
Robert T WheelerDepartment of Molecular and Biomedical Sciences, University of Maine, Orono, Maine, USA.
Mitchel J DoktyczBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Todd B ReynoldsDepartment of Microbiology, University of Tennessee, Knoxville, Tennessee, USA treynol6@utk.edu.
University of Tennessee at Knoxville · USOak Ridge National Laboratory · USUniversity of Maine · US

Funding

Screen for phosphatidylserine synthase inhibitors: antifungals & lipid probesR01AI105690 · NIAID · UNIVERSITY OF TENNESSEE KNOXVILLE · PI REYNOLDS, TODD B · 2013 to 2015
$1.2M
NIAID NIH HHS R01 AI105690
6 · The paper itself

Abstract

Candida albicans is among the most common human fungal pathogens, causing a broad range of infections, including life-threatening systemic infections. The cell wall of C. albicans is the interface between the fungus and the innate immune system. The cell wall is composed of an outer layer enriched in mannosylated glycoproteins (mannan) and an inner layer enriched in β-(1,3)-glucan and chitin. Detection of C. albicans by Dectin-1, a C-type signaling lectin specific for β-(1,3)-glucan, is important for the innate immune system to recognize systemic fungal infections. Increased exposure of β-(1,3)-glucan to the immune system occurs when the mannan layer is altered or removed in a process called unmasking. Nanoscale changes to the cell wall during unmasking were explored in live cells with atomic force microscopy (AFM). Two mutants, the cho1Δ/Δ and kre5Δ/Δ mutants, were selected as representatives that exhibit modest and strong unmasking, respectively. Comparisons of the cho1Δ/Δ and kre5Δ/Δ mutants to the wild type reveal morphological changes in their cell walls that correlate with decreases in cell wall elasticity. In addition, AFM tips functionalized with Dectin-1 revealed that the forces of binding of Dectin-1 to all of the strains were similar, but the frequency of binding was highest for the kre5Δ/Δ mutant, decreased for the cho1Δ/Δ mutant, and rare for the wild type. These data show that nanoscale changes in surface topology are correlated with increased Dectin-1 adhesion and decreased cell wall elasticity. AFM, using tips functionalized with immunologically relevant molecules, can map epitopes of the cell wall and increase our understanding of pathogen recognition by the immune system.

Indexed as

beta-GlucansCandida albicansCell MembraneCell WallChitinDectin-1ElasticityLectins, C-TypeMannansMutationbeta-GlucansChitinDectin-1Lectins, C-TypeMannansadhesion force mappingatomic force microscopyCandida albicanscaspofunginDectin-1elasticitygelatin immobilizationindentation force mappingmacrophagesYoung's modulusβ-(1,3)-glucan

Identifiers

PMID27849179
PMCPMC5203643
OpenAlexW2556667708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.